Viewing StudyNCT06015126



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06015126
Status: RECRUITING
Last Update Posted: 2023-08-29
First Post: 2023-08-08

Brief Title: Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Sponsor: Yan Xue
Organization: Xian International Medical Center Hospital

Organization Data

Organization: Xian International Medical Center Hospital
Class: OTHER
Study ID: Y-pierrefabre202102-0108
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Yan Xue
Lead Sponsor Class: OTHER
Responsible Party: Yan Xue
Responsible Party Title: Director of tumor hospital
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation: Xian International Medical Center Hospital
Old Name: None
Old Organization: None

Collaborators